Navigation Links
Andrew P. Mandell - Mr. Diabetes(R) to Sit On ProtoKinetix Advisory Board
Date:1/15/2010

MADEIRA BEACH, Fla., Jan. 15 /PRNewswire/ -- Andrew P. Mandell – Mr. Diabetes®, Executive Director of Defeat Diabetes Foundation and diabetes advocate announced today that he will be sitting on the ProtoKinetix (PKTX) Advisory Board.  ProtoKinetix, Inc. is a biotechnology company that has developed and patented a family of synthetic anti-aging glycoproteins (AAGP™) for medicine and the biotechnology and cosmetic industries.

"I'm really excited about their technology and it's potential to offer the first truly viable long term treatment for diabetes," said Mandell. "The Protokinetix's research team has made remarkable progress in the harvesting and preservation of stem cells for islet transplantation for diabetes treatments," he continued.

"In addition to the potential treatments for diabetes, AAGP™ also shows great promise in many other medical applications. I'm really looking forward to contributing where I can to support their work," Mandell concluded.

Defeat Diabetes Foundation

Defeat Diabetes Foundation is a 501(c)(3) nonprofit  whose mission is the prevention, early identification and effective self management of diabetes.

DDF has awareness and interactive programs in all 50 states to provide critical information and education programs with a focus on diabetes, nutrition and physical fitness. Their public information programs include the KIDD™ Project which has provided millions of Free Defeat Diabetes® Screening Test brochures to schools in all 50 states, the DAN Project, a Public Service Announcements program and the Martial Arts Defeat Diabetes® Community Action Project (MADDCAP™) a historic health curriculum for martial arts schools and their students.

For information on diabetes, to take the free screening test or obtain additional information visit: www.DefeatDiabetes.org

For information on ProtoKinetix visit the website at: www.protokinetix.com

The Private Securities Litigation Reform Act of 1995 provides a "safe harbor" for forward-looking statements. Some information included in this press release contains statements that are forward-looking. Such forward-looking information involves significant risks and uncertainties that could affect anticipated results in the future and, accordingly, these results may differ materially from those expressed in any forward-looking statements made by or on behalf of the Company. For a description of additional risks and uncertainties, please refer to the Company's filings with the Securities and Exchange Commission.

SOURCE Defeat Diabetes Foundation

RELATED LINKS
http://www.defeatdiabetes.org/
http://www.protokinetix.com/

'/>"/>

SOURCE Defeat Diabetes Foundation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Vical Names Andrew de Guttadauro Vice President, Corporate Development
2. MacAndrews & Forbes Names Barry F. Schwartz as Executive Vice Chairman
3. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
4. 5AM Ventures Announces Expansion of Investment Team: Names Richard Ulevitch Venture Partner; Promotes Kevin Forrest and Andrew McMillan to Principal
5. [video] Ronald Andrews, CEO of Clarient, Inc. Discusses Agreement With University of Pennsylvania School of Medicine on WallSt.nets 3-Minute Press Show
6. Algeta Appoints Andrew Kay as President and Chief Executive Officer
7. Andrew Chisholm Appointed Vice President, Sales and Corporate Accounts at Accumetrics
8. Veridiam Appoints Andrew Gale as Chief Executive Officer
9. BioNeutral Groups CEO, Stephen Browand and Chief Scientist, Dr. Andrew Kielbania to Appear on WVOX 1460 AM In Focus Radio Show Hosted by Dr. Dan Miller
10. Jonathan Moreno and Andrew Light Speak About Biotechnology and Global Warming at the National Press Club
11. ProtoKinetix Partners with OTC Financial Network to Increase Shareholder Base
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/28/2017)... Research Triangle Park, NC (PRWEB) , ... March ... ... drug development company engaged in the development of a new orally administered treatment ... Company’s Advisory Board. , CEO John Didsbury states, “As we seek to uniquely ...
(Date:3/27/2017)... -- Cousins Properties (NYSE: CUZ ) announced today ... signed a 10-year, approximately 125,000 square-foot lease at Corporate Center, ... the Westshore submarket of Tampa, FL. ... Corporate Center for their new location in Tampa ... executive officer of Cousins Properties. "Amgen is a cutting-edge global ...
(Date:3/27/2017)... Va. , March 27, 2017  Perthera,s Chief ... Cancer Center, Subha Madhavan , Ph.D., will be ... Joint Summits Panels. On Monday, March 27, 2017, she ... Oncology Data More Usable for Research and Care" (from ... March 28, 2017, she will be a participant in ...
(Date:3/27/2017)... SAN DIEGO , March 27, 2017  Trovagene, ... announced that its Chief Executive Officer, Bill Welch ... on April 4, 2017 at 9:00 AM EDT at ... .  Bill Welch, and Chief Scientific Officer, ... meet with investors during the conference.   The ...
Breaking Biology Technology:
(Date:3/24/2017)... -- The Controller General of Immigration from Maldives Mr. ... have received the prestigious international IAIR Award for the most innovative high ... ... Maldives Immigration Controller ... (small picture on the right) have received the IAIR award for the ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
(Date:3/22/2017)... 2017   Neurotechnology , a provider of ... announced the release of the SentiVeillance 6.0 ... facial recognition using up to 10 surveillance, security ... The new version uses deep neural-network-based facial detection ... utilizes a Graphing Processing Unit (GPU) for enhanced ...
Breaking Biology News(10 mins):